Edwards Lifesciences PE Ratio 2010-2022 | EW

Current and historical p/e ratio for Edwards Lifesciences (EW) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Edwards Lifesciences PE ratio as of September 23, 2022 is 37.17.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Edwards Lifesciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-09-26 83.59 36.19
2022-06-30 95.09 $2.31 41.16
2022-03-31 117.72 $2.44 48.25
2021-12-31 129.55 $2.39 54.21
2021-09-30 113.21 $2.35 48.17
2021-06-30 103.57 $2.33 44.45
2021-03-31 83.64 $1.35 61.96
2020-12-31 91.23 $1.30 70.18
2020-09-30 79.82 $1.25 63.86
2020-06-30 69.11 $1.16 59.41
2020-03-31 62.87 $1.74 36.07
2019-12-31 77.76 $1.65 47.23
2019-09-30 73.30 $1.22 60.25
2019-06-30 61.58 $1.14 54.18
2019-03-31 63.78 $1.20 53.30
2018-12-31 51.06 $0.86 59.37
2018-09-30 58.03 $1.11 52.13
2018-06-30 48.52 $1.05 46.36
2017-12-31 37.57 $0.96 39.14
2017-09-30 36.44 $1.15 31.78
2017-06-30 39.41 $1.20 32.75
2017-03-31 31.36 $1.13 27.67
2016-12-31 31.23 $0.97 32.09
2018-03-31 46.51 $0.95 48.95
2016-09-30 40.19 $0.84 47.65
2016-06-30 33.24 $0.80 41.30
2016-03-31 29.40 $0.78 37.62
2015-12-31 26.33 $0.75 35.18
2015-09-30 23.70 $0.70 33.77
2015-06-30 23.74 $0.67 35.52
2015-03-31 23.74 $1.35 17.63
2014-12-31 21.23 $1.25 16.94
2014-09-30 17.03 $1.20 14.19
2014-06-30 14.31 $1.17 12.25
2014-03-31 12.36 $0.46 27.07
2013-12-31 10.96 $0.57 19.23
2013-09-30 11.61 $0.59 19.84
2013-06-30 11.20 $0.57 19.70
2013-03-31 13.69 $0.53 26.00
2012-12-31 15.03 $0.41 36.50
2012-09-30 17.90 $0.37 48.14
2012-06-30 17.22 $0.35 49.66
2012-03-31 12.12 $0.33 36.54
2011-12-31 11.78 $0.33 35.71
2011-09-30 11.88 $0.31 38.52
2011-06-30 14.53 $0.32 45.88
2010-12-31 13.47 $0.30 44.41
2010-09-30 11.18 $0.28 39.90
2010-06-30 9.34 $0.30 30.95
2010-03-31 8.24 $0.33 25.28
2009-12-31 7.24 $0.33 22.15
2011-03-31 14.50 $0.35 41.93
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $52.534B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Alcon (ALC) Switzerland $29.415B 24.91
STERIS (STE) Ireland $16.731B 20.78
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19